A clinical approach to the nutritional care process in protein-energy wasting hemodialysis patients;Enfoque clínico de atención nutricional en pacientes con desgaste protéico-energético en hemodiálisis

Nutricion Hospitalaria

Volumn 29, Issue 4, 2014, Pages 735-750

  Ruperto, Mar ^a   Sánchez Muniz, Francisco J ^a   Barril, Guillermina ^b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Cachexia; Hemodialysis; Malnutrition; Nutritional care process; Nutritional support; Proteinenergy wating

Indexed keywords

PROTEIN INTAKE;

ADMINISTRATION AND DOSAGE; ADVERSE EFFECTS; DIET THERAPY; HUMAN; MALNUTRITION; METABOLISM; MORTALITY; PROCEDURES; PROTEIN INTAKE; RENAL REPLACEMENT THERAPY;

DIETARY PROTEINS; HUMANS; MALNUTRITION; NUTRITION THERAPY; RENAL DIALYSIS;

EID: 84897934678     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2014.29.4.7222     Document Type: Review

References (129)

1. Kyle UG, Pirlich M, Schuetz T, Luebke HJ, Lochs H, Pichard C. Prevalence of malnutrition in 1760 patients at hospital admission: a controlled population study of body composition. Clin Nutr 2003; 22: 473-81.
2. Beddhu S, Cheung AK, Larive B et al. Inflammation and inverse associations of body mass index and serum creatinine with mortality in hemodialysis patients. J Ren Nutr 2007; 17: 372-80.
3. Mehrotra R, Berman N, Alistwani A, Kopple JD. Improvement of nutritional status after initiation of maintenance hemodialy - sis. Am J Kidney Dis 2002; 40: 133-42.
4. USRD. US Renal Data System. USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2010.
5. Lopes AA, Bragg-Gresham JL, Elder SJ et al. Independent and joint associations of nutritional status indicators with mortality risk among chronic hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Ren Nutr 2010; 20: 224-34.
6. de MR, Grootendorst DC, Axelsson J, Boeschoten EW, Krediet RT, Dekker FW. Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients. Nephrol Dial Transplant 2008; 23: 2957-64.
7. Gracia-Iguacel C, Gonzalez-Parra E, Perez-Gomez MV et al. Prevalence of protein-energy wasting syndrome and its association with mortality in haemodialysis patients in a centre in Spain. Nefrologia 2013; 33: 495-505.
8. Stenvinkel P, Heimburger O, Paultre F et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999; 55: 1899-911.
9. Kovesdy CP, Kalantar-Zadeh K. Why is protein-energy wasting associated with mortality in chronic kidney disease? Semin Nephrol 2009; 29: 3-14.
10. Fouque D, Kalantar-Zadeh K, Kopple J et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 2008; 73: 391-8.
11. Ikizler TA, Cano NJ, Franch H et al. Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism. Kidney Int 2013: 22 (Epub ahead of print).
12. Johnson DW. KHA-CARI Guideline: Early chronic kidney disease: detection, prevention and management. Nephrology 2013; 18: 340-50.
13. Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation. Am J Kidney Dis 2000; 35: S1-140.
14. Memmer D. Implementation and practical application of the nutrition care process in the dialysis unit. J Ren Nutr 2013; 23: 65-73.
15. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 2003; 63: 793-808.
16. Fleischmann E, Teal N, Dudley J, May W, Bower JD, Salahudeen AK. Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients. Kidney Int 1999; 55: 1560-7.
17. Fleischmann EH, Bower JD, Salahudeen AK. Are conventional cardiovascular risk factors predictive of two-year mortality in hemodialysis patients? Clin Nephrol 2001; 56: 221-30.
18. Beddhu S, Pappas LM, Ramkumar N, Samore M. Effects of body size and body composition on survival in hemodialysis patients. J Am Soc Nephrol 2003; 14: 2366-72.
19. Axelsson J, Rashid QA, Suliman ME et al. Truncal fat mass as a contributor to inflammation in end-stage renal disease. Am J Clin Nutr 2004; 80: 1222-9.
20. Odamaki M, Furuya R, Ohkawa S et al. Altered abdominal fat distribution and its association with the serum lipid profile in non-diabetic haemodialysis patients. Nephrol Dial Transplant 1999; 14: 2427-32.
21. Gohda T, Gotoh H, Tanimoto M et al. Relationship between abdominal fat accumulation and insulin resistance in hemodialy - sis patients. Hypertens Res 2008; 31: 83-8.
22. Gotoh H, Gohda T, Tanimoto M, Gotoh Y, Horikoshi S, Tomino Y. Contribution of subcutaneous fat accumulation to insulin resistance and atherosclerosis in haemodialysis patients. Nephrol Dial Transplant 2009; 24: 3474-80.
23. Postorino M, Marino C, Tripepi G, Zoccali C. Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease. J Am Coll Cardiol 2009; 53: 1265-72.
24. Cordeiro AC, Qureshi AR, Stenvinkel P et al. Abdominal fat deposition is associated with increased inflammation, proteinenergy wasting and worse outcome in patients undergoing haemodialysis. Nephrol Dial Transplant 2010; 25: 562-8.
25. Postorino M, Marino C, Tripepi G, Zoccali C. Abdominal obesity modifies the risk of hypertriglyceridemia for all-cause and cardiovascular mortality in hemodialysis patients. Kidney Int 2011; 79: 765-72.
26. Zoccali C, Postorino M, Marino C, Pizzini P, Cutrupi S, Tripepi G. Waist circumference modifies the relationship between the adipose tissue cytokines leptin and adiponectin and all-cause and cardiovascular mortality in haemodialysis patients. J Intern Med 2011; 269: 172-81.
27. Lowrie EG, Lew NL. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990; 15: 458-82.
28. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol 1996; 7: 728-36.
29. Owen WF, Lowrie EG. C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int 1998; 54: 627-36.
30. Beddhu S, Kaysen GA, Yan G et al. Association of serum albumin and atherosclerosis in chronic hemodialysis patients. Am J Kidney Dis 2002; 40: 721-7.
31. Kato A, Takita T, Furuhashi M, Maruyama Y, Hishida A. Comparison of serum albumin, C-reactive protein and carotid atherosclerosis as predictors of 10-year mortality in hemodialysis patients. Hemodial Int 2010; 14: 226-32.
32. de MR, Grootendorst DC, Indemans F, Boeschoten EW, Krediet RT, Dekker FW. Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition. J Ren Nutr 2009; 19: 127-35.
33. Chertow GM, Goldstein-Fuchs DJ, Lazarus JM, Kaysen GA. Prealbumin, mortality, and cause-specific hospitalization in hemodialysis patients. Kidney Int 2005; 68: 2794-800.
34. Rambod M, Kovesdy CP, Bross R, Kopple JD, Kalantar-Zadeh K. Association of serum prealbumin and its changes over time with clinical outcomes and survival in patients receiving hemodialysis. Am J Clin Nutr 2008; 88: 1485-94.
35. Herselman M, Esau N, Kruger JM, Labadarios D, Moosa MR. Relationship between serum protein and mortality in adults on long-term hemodialysis: exhaustive review and meta-analysis. Nutrition 2010; 26: 10-32.
36. Beberashvili I, Sinuani I, Azar A et al. IL-6 levels, nutritional status, and mortality in prevalent hemodialysis patients. Clin J Am Soc Nephrol 2011; 6: 2253-63.
37. Bologa RM, Levine DM, Parker TS et al. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 1998; 32: 107-14.
38. Honda H, Qureshi AR, Heimburger O et al. Serum albumin, Creactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis 2006; 47: 139-48.
39. Zhang W, He J, Zhang F et al. Prognostic role of C-reactive protein and interleukin-6 in dialysis patients: a systematic review and meta-analysis. J Nephrol 2013; 26: 243-53.
40. Zoccali C, Benedetto FA, Mallamaci F et al. Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed Investigators. Cardiovascular Risk Extended Evaluation in Dialysis Patients. J Hypertens 2000; 18: 1207-13.
41. Lee PS, Sampath K, Karumanchi SA et al. Plasma gelsolin and circulating actin correlate with hemodialysis mortality. J Am Soc Nephrol 2009; 20: 1140-8.
42. Miyamoto T, Carrero JJ, Qureshi AR et al. Circulating follistatin in patients with chronic kidney disease: implications for muscle strength, bone mineral density, inflammation, and survival. Clin J Am Soc Nephrol 2011; 6: 1001-8.
43. Kalantar-Zadeh K, Block G, McAllister CJ, Humphreys MH, Kopple JD. Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients. Am J Clin Nutr 2004; 80: 299-307.
44. Ruperto M, Sánchez-Muniz FJ, Barril G. Plasma leptin levels and inflammation biomarkers in well nourished and malnou - rished haemodialysed patients [abstract] Proceeding of Nutrition Society 2010; 69: 265.
45. Muscaritoli M, Molfino A, Chiappini MG et al. Anorexia in hemodialysis patients: the possible role of des-acyl ghrelin. Am J Nephrol 2007; 27: 360-5.
46. Carrero JJ, Nakashima A, Qureshi AR et al. Protein-energy wasting modifies the association of ghrelin with inflammation, leptin, and mortality in hemodialysis patients. Kidney Int 2011; 79: 749-56.
47. Axelsson J, Witasp A, Carrero JJ et al. Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD. Am J Kidney Dis 2007; 49: 237-44.
48. Carrero JJ, Witasp A, Stenvinkel P et al. Visfatin is increased in chronic kidney disease patients with poor appetite and correlates negatively with fasting serum amino acids and triglyceride levels. Nephrol Dial Transplant 2010; 25: 901-6.
49. Keys A., Brozek J, Hensschel A, Mickelsen O, Taylor HL. The biology of human starvation. The University of Minnesota Press, Minneapolis 1950. p. 63-130.
50. Bistrian BR, McCowen KC, Chan S. Protein-energy malnutrition in dialysis patients. Am J Kidney Dis 1999; 33: 172-5.
51. Chazot C, Laurent G, Charra B et al. Malnutrition in long-term haemodialysis survivors. Nephrol Dial Transplant 2001; 16: 61-9.
52. Kaysen GA. Association between inflammation and malnutrition as risk factors of cardiovascular disease. Blood Purif 2006; 24: 51-5.
53. Kaysen GA, Stevenson FT, Depner TA. Determinants of albumin concentration in hemodialysis patients. Am J Kidney Dis 1997; 29: 658-68.
54. Iseki K, Tozawa M, Yoshi S, Fukiyama K. Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients. Nephrol Dial Transplant 1999; 14: 1956-60.
55. Carrero JJ, Nakashima A, Qureshi AR et al. Protein-energy wasting modifies the association of ghrelin with inflammation, leptin, and mortality in hemodialysis patients. Kidney Int 2011; 79: 749-56.
56. Evans WJ, Morley JE, Argiles J et al. Cachexia: a new definition. Clin Nutr 2008; 27: 793-9.
57. Academy of Nutrition and Dietetics. International Dietetic and Nutrition Terminology (IDNT) Reference Manual: Standardized Language for the Nutrition Care process. 2013.
58. Lacey K, Pritchett E. Nutrition Care Process and Model: ADA adopts road map to quality care and outcomes management. J Am Diet Assoc 2003; 103: 1061-72.
59. Fouque D, Vennegoor M, ter WP et al. EBPG guideline on nutrition. Nephrol Dial Transplant 2007; 22 Suppl 2: ii45-ii87.
60. Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH. A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis 2001; 38: 1251-63.
61. Elsurer R, Afsar B, Sezer S, Arat Z, Ozdemir FN, Haberal M. Malnutrition inflammation score is associated with coronary artery disease in hepatitis C virus-infected hemodialysis patients. Eur J Clin Nutr 2008; 62: 1449-54.
62. Aguilera A, Sanchez-Tomero JA, Bajo MA et al. Malnutritioninflammation syndrome is associated with endothelial dysfunction in peritoneal dialysis patients. Adv Perit Dial 2003; 19: 240-5.
63. Rambod M, Bross R, Zitterkoph J et al. Association of Malnutrition- Inflammation Score with quality of life and mortality in hemodialysis patients: a 5-year prospective cohort study. Am J Kidney Dis 2009; 53: 298-309.
64. Kalantar-Zadeh K, McAllister CJ, Lehn RS, Lee GH, Nissenson AR, Kopple JD. Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients. Am J Kidney Dis 2003; 42: 761-73.
65. Chertow GM, Lazarus JM, Lew NL, Ma L, Lowrie EG. Bioimpedance norms for the hemodialysis population. Kidney Int 1997; 52: 1617-21.
66. Chertow GM, Jacobs C, Lazarus JM, Lew N, Lowrie EG. Phase angle predicts survival in hemodialysis patients. J Ren Nutr 1997; 7: 204-7.
67. Ruperto M, Barril G., Sánchez-Muniz FJ, Cigarran S., Sánchez Tomero JA. El ángulo de fase es un parámetro de utilidad diagnóstica del síndrome de malnutrición-inflamación en pacientes prevalentes en hemodiálisis periódica. Nutr Hosp 2010; 25 (Supl. 1): 3.
68. Brown RO, Compher C. A.S.P.E.N. clinical guidelines: nutrition support in adult acute and chronic renal failure. JPEN 2010; 34: 366-77.
69. Cheung AK, Levin NW, Greene T et al. Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO study. J Am Soc Nephrol 2003; 14: 3251-63.
70. Huarte E, Barril G, Cebollada J, Cerezo S, Coronel F, Doñate T et al. Consenso de Nutrición y Diálisis. Dial Traspl. 2006; 27: 138-61.
71. Culleton BF, Walsh M, Klarenbach SW et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA 2007; 298: 1291-9.
72. Barrett BJ, Parfrey PS, Morgan J et al. Prediction of early death in end-stage renal disease patients starting dialysis. Am J Kidney Dis 1997; 29: 214-22.
73. Perl J, Chan CT. Home hemodialysis, daily hemodialysis, and nocturnal hemodialysis: Core Curriculum 2009. Am J Kidney Dis 2009; 54: 1171-84.
74. Chertow GM, Levin NW, Beck GJ et al. In-center hemodialysis six times per week versus three times per week. N Engl J Med 2010; 363: 2287-300.
75. Rocco MV, Larive B, Eggers PW et al. Baseline characteristics of participants in the Frequent Hemodialysis Network (FHN) daily and nocturnal trials. Am J Kidney Dis 2011; 57: 90-100.
76. Pedrini LA, De C, V, Comelli M et al. Long-term effects of high-efficiency on-line haemodiafiltration on uraemic toxicity. A multicentre prospective randomized study. Nephrol Dial Transplant 2011; 26: 2617-24.
77. Ayus JC, Achinger SG, Mizani MR et al. Phosphorus balance and mineral metabolism with 3 h daily hemodialysis. Kidney Int 2007; 71: 336-42.
78. Grooteman MP, van den Dorpel MA, Bots ML et al. Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes. J Am Soc Nephrol 2012; 23: 1087-96.
79. Gross M, Maierhofer A, Tetta C, Senecal L, Canaud B. Online clearance measurement in high-efficiency hemodiafiltration. Kidney Int 2007; 72: 1550-3.
80. Toigo G, Aparicio M, Attman PO et al. Expert Working Group report on nutrition in adult patients with renal insufficiency (part 1 of 2). Clin Nutr 2000; 19: 197-207.
81. Burrowes JD, Larive B, Cockram DB et al. Effects of dietary intake, appetite, and eating habits on dialysis and non-dialysis treatment days in hemodialysis patients: cross-sectional results from the HEMO study. J Ren Nutr 2003; 13: 191-8.
82. Bossola M, Muscaritoli M, Tazza L et al. Malnutrition in hemodialysis patients: what therapy? Am J Kidney Dis 2005; 46: 371-86.
83. Wilson B, Fernandez-Madrid A, Hayes A, Hermann K, Smith J, Wassell A. Comparison of the effects of two early intervention strategies on the health outcomes of malnourished hemodialysis patients. J Ren Nutr 2001; 11: 166-71.
84. Cano NJ, Aparicio M, Brunori G et al. ESPEN Guidelines on Parenteral Nutrition: adult renal failure. Clin Nutr 2009; 28: 401-14.
85. Kalantar-Zadeh K, Cano NJ, Budde K et al. Diets and enteral supplements for improving outcomes in chronic kidney disease. Nat Rev Nephrol 2011; 7: 369-84.
86. Beutler KT, Park GK, Wilkowsky MJ. Effect of oral supplementation on nutrition indicators in hemodialysis patients. J Ren Nutr 1997; 7: 77-82.
87. Lacson E Jr, Wang W, Zebrowski B, Wingard R, Hakim RM. Outcomes associated with intradialytic oral nutritional supplements in patients undergoing maintenance hemodialysis: a quality improvement report. Am J Kidney Dis 2012; 60: 591-600.
88. Caglar K, Fedje L, Dimmitt R, Hakim RM, Shyr Y, Ikizler TA. Therapeutic effects of oral nutritional supplementation during hemodialysis. Kidney Int 2002; 62: 1054-9.
89. Cockram DB, Hensley MK, Rodriguez M et al. Safety and tolerance of medical nutritional products as sole sources of nutrition in people on hemodialysis. J Ren Nutr 1998; 8: 25-33.
90. Fouque D, McKenzie J, de MR et al. Use of a renal-specific oral supplement by haemodialysis patients with low protein intake does not increase the need for phosphate binders and may prevent a decline in nutritional status and quality of life. Nephrol Dial Transplant 2008; 23: 2902-10.
91. Rattanasompattikul M, Molnar MZ, Lee ML et al. Anti-Inflammatory and Anti-Oxidative Nutrition in Hypoalbuminemic Dialysis Patients (AIONID) study: results of the pilot-feasibility, double-blind, randomized, placebo-controlled trial. J Cachexia Sarcopenia Muscle 2013; 4: 247-57.
92. Cano N, Fiaccadori E, Tesinsky P et al. ESPEN Guidelines on Enteral Nutrition: Adult renal failure. Clin Nutr 2006; 25: 295- 310.
93. Kooman J, Basci A, Pizzarelli F et al. EBPG guideline on haemodynamic instability. Nephrol Dial Transplant 2007; 22 Suppl 2: ii22-ii44.
94. Dezfuli A, Scholl D, Lindenfeld SM, Kovesdy CP, Kalantar- Zadeh K. Severity of hypoalbuminemia predicts response to intradialytic parenteral nutrition in hemodialysis patients. J Ren Nutr 2009; 19: 291-7.
95. Joannidis M, Rauchenzauner M, Leiner B et al. Effect of intradialytic parenteral nutrition in patients with malnutritioninflammation complex syndrome on body weight, inflammation, serum lipids and adipocytokines: results from a pilot study. Eur J Clin Nutr 2008; 62: 789-95.
96. Foulks CJ. The effect of intradialytic parenteral nutrition on hospitalization rate and mortality in malnourished hemodialysis patients. J Ren Nutr 1994; 4: 5-10.
97. Chertow GM, Ling J, Lew NL, Lazarus JM, Lowrie EG. The association of intradialytic parenteral nutrition administration with survival in hemodialysis patients. Am J Kidney Dis 1994; 24: 912-20.
98. Cano NJ, Fouque D, Roth H et al. Intradialytic parenteral nutrition does not improve survival in malnourished hemodialysis patients: a 2-year multicenter, prospective, randomized study. J Am Soc Nephrol 2007; 18: 2583-91.
99. Pupim LB, Flakoll PJ, Brouillette JR, Levenhagen DK, Hakim RM, Ikizler TA. Intradialytic parenteral nutrition improves protein and energy homeostasis in chronic hemodialysis patients. J Clin Invest 2002; 110: 483-92.
100. Pupim LB, Flakoll PJ, Ikizler TA. Exercise improves albumin fractional synthetic rate in chronic hemodialysis patients. Eur J Clin Nutr 2007; 61: 686-9.
101. Ikizler TA, Flakoll PJ, Parker RA, Hakim RM. Amino acid and albumin losses during hemodialysis. Kidney Int 1994; 46: 830- 7.
102. Pupim LB, Majchrzak KM, Flakoll PJ, Ikizler TA. Intradialytic oral nutrition improves protein homeostasis in chronic hemodialysis patients with deranged nutritional status. J Am Soc Nephrol 2006; 17: 3149-57.
103. Nagahuedi S, Popesku JT, Trudeau VL, Weber JM. Mimicking the natural doping of migrant sandpipers in sedentary quails: effects of dietary n-3 fatty acids on muscle membranes and PPAR expression. J Exp Biol 2009; 212: 1106-14.
104. Kopple JD, Wang H, Casaburi R et al. Exercise in maintenance hemodialysis patients induces transcriptional changes in genes favoring anabolic muscle. J Am Soc Nephrol 2007; 18: 2975- 86.
105. Perunicic-Pekovic GB, Rasic ZR, Pljesa SI et al. Effect of n-3 fatty acids on nutritional status and inflammatory markers in haemodialysis patients. Nephrology (Carlton) 2007; 12: 331-6.
106. Saifullah A, Watkins BA, Saha C, Li Y, Moe SM, Friedman AN. Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients -a pilot study. Nephrol Dial Transplant 2007; 22: 3561-7.
107. Garibotto G, Barreca A, Sofia A et al. Effects of growth hormone on leptin metabolism and energy expenditure in hemodialysis patients with protein-calorie malnutrition. J Am Soc Nephrol 2000; 11: 2106-13.
108. Biolo G, Ciocchi B, Bosutti A, Situlin R, Toigo G, Guarnieri G. Pentoxifylline acutely reduces protein catabolism in chronically uremic patients. Am J Kidney Dis 2002; 40: 1162-72.
109. Garibotto G, Barreca A, Russo R et al. Effects of recombinant human growth hormone on muscle protein turnover in malnourished hemodialysis patients. J Clin Invest 1997; 99: 97- 105.
110. Wynne K, Giannitsopoulou K, Small CJ et al. Subcutaneous ghrelin enhances acute food intake in malnourished patients who receive maintenance peritoneal dialysis: a randomized, placebo-controlled trial. J Am Soc Nephrol 2005; 16: 2111-8.
111. Ashby DR, Ford HE, Wynne KJ et al. Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment. Kidney Int 2009; 76: 199-206.
112. Caso G, Garlick PJ. Control of muscle protein kinetics by acidbase balance. Curr Opin Clin Nutr Metab Care 2005; 8: 73-6.
113. Cheung WW, Kuo HJ, Markison S et al. Peripheral administration of the melanocortin-4 receptor antagonist NBI-12i ameliorates uremia-associated cachexia in mice. J Am Soc Nephrol 2007; 18: 2517-24.
114. Stubbs JR, Idiculla A, Slusser J, Menard R, Quarles LD. Cholecalciferol supplementation alters calcitriol-responsive monocyte proteins and decreases inflammatory cytokines in ESRD. J Am Soc Nephrol 2010; 21: 353-61.
115. Himmelfarb J, Phinney S, Ikizler TA, Kane J, McMonagle E, Miller G. Gamma-tocopherol and docosahexaenoic acid decrease inflammation in dialysis patients. J Ren Nutr 2007; 17: 296-304.
116. Johansen KL. The role of nandrolone decanoate in patients with end stage renal disease in the erythropoietin era. Int J Artif Organs 2001; 24: 183-5.
117. Johansen KL, Painter PL, Sakkas GK, Gordon P, Doyle J, Shubert T. Effects of resistance exercise training and nandrolone decanoate on body composition and muscle function among patients who receive hemodialysis: A randomized, controlled trial. J Am Soc Nephrol 2006; 17: 2307-14.
118. May PE, Barber A, D'Olimpio JT, Hourihane A, Abumrad NN. Reversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine. Am J Surg 2002; 183: 471-9.
119. Clark RH, Feleke G, Din M et al. Nutritional treatment for acquired immunodeficiency virus-associated wasting using beta-hydroxy beta-methylbutyrate, glutamine, and arginine: a randomized, double-blind, placebo-controlled study. JPEN J Parenter Enteral Nutr 2000; 24: 133-9.
120. Rathmacher JA, Nissen S, Panton L et al. Supplementation with a combination of beta-hydroxy-beta-methylbutyrate (HMB), arginine, and glutamine is safe and could improve hematological parameters. JPEN J Parenter Enteral Nutr 2004; 28: 65-75.
121. Stenvinkel P, Heimburger O, Lindholm B, Kaysen GA, Bergstrom J. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant 2000; 15: 953-60.
122. Milano MC, Cusumano AM, Navarro ET, Turin M. Energy supplementation in chronic hemodialysis patients with moderate and severe malnutrition. J Ren Nutr 1998; 8: 212-7.
123. Kuhlmann MK, Schmidt F, Kohler H. High protein/energy vs. standard protein/energy nutritional regimen in the treatment of malnourished hemodialysis patients. Miner Electrolyte Metab 1999; 25: 306-10.
124. Patel MG, Kitchen S, Miligan PJ. The effect of dietary supplements on the nPCR in stable hemodialysis patients. J Ren Nutr 2000; 10: 69-75.
125. Sharma M, Rao M, Jacob S, Jacob CK. A controlled trial of intermittent enteral nutrient supplementation in maintenance hemodialysis patients. J Ren Nutr 2002; 12: 229-37.
126. Kalantar-Zadeh K, Braglia A, Chow J et al. An anti-inflammatory and antioxidant nutritional supplement for hypoalbuminemic hemodialysis patients: a pilot/feasibility study. J Ren Nutr 2005; 15: 318-31.
127. Leon JB, Albert JM, Gilchrist G et al. Improving albumin levels among hemodialysis patients: a community-based randomized controlled trial. Am J Kidney Dis 2006; 48: 28-36.
128. Scott MK, Shah NA, Vilay AM, Thomas J, III, Kraus MA, Mueller BA. Effects of peridialytic oral supplements on nutritional status and quality of life in chronic hemodialysis patients. J Ren Nutr 2009; 19: 145-52.
129. Malgorzewicz S, Rutkowski P, Jankowska M, Debska-Slizien A, Rutkowski B, Lysiak-Szydlowska W. Effects of renalspecific oral supplementation in malnourished hemodialysis patients. J Ren Nutr 2011; 21: 347-53. 750